Skip to main content
Understanding the Short- and Long-Term Respiratory Outcomes of Prematurity and Bronchopulmonary Dysplasia.
Implications of the U.S. Food and Drug Administration warning against the use of sildenafil for the treatment of pediatric pulmonary hypertension.
Congenital diaphragmatic hernia: endothelin-1, pulmonary hypertension, and disease severity.
Postnatal estradiol up-regulates lung nitric oxide synthases and improves lung function in bronchopulmonary dysplasia.
Treatment outcomes of patients with HIV and tuberculosis.
Nuclear factor-kappaB activation in neonatal mouse lung protects against lipopolysaccharide-induced inflammation.
Effect of ductus ligation on cardiopulmonary function in premature baboons.
Pediatric acute lung injury: prospective evaluation of risk factors associated with mortality.
Surfactant protein profile of pulmonary surfactant in premature infants.
Arginine therapy: a new treatment for pulmonary hypertension in sickle cell disease?